Title

Monthly Plenary Series

Today's Science Can't Wait

 

Designed to keep clinicians current on new and emerging research in between meetings, the ASCO Plenary Series provides a monthly online forum for presentation and discussion of the latest cancer research. The Plenary Series will provide faster dissemination of practice-changing science to better help clinicians deliver the most up-to-date care and treatments to patients with cancer.

Each monthly program will feature up to two practice-changing and clinically relevant abstracts on the latest advances in cancer care. The live abstract presentation will be accompanied by a discussant presentation and followed by a live question-and-answer session.

Dates to Know

The ASCO Plenary Series will take place monthly through April and will resume after the ASCO Annual Meeting. Featured abstracts will be released at 5:00 PM ET the day prior to presentation. Mark your calendar for the following dates:

  November Session December Session January Session February Session March Session April Session
Abstract Submission Deadline Oct. 5, 2021 Nov. 2, 2021 Dec. 7, 2021 Jan. 4, 2022 Feb. 1, 2022 Mar. 1, 2022
Author Notification Oct. 20, 2021 Nov. 17, 2021 Dec. 22, 2021 Jan. 20, 2022 Feb. 16, 2022 Mar. 16, 2022
Abstract Presentation Nov. 16, 2021 Dec. 14, 2021 Jan. 25, 2022 Feb. 15, 2022 Mar. 15, 2022 Apr. 19, 2022

Abstract Submission and Presentation

 

Submit an Abstract

You don’t have to wait for the next meeting to maximize the visibility and impact of your research.

  • The ASCO Plenary Series provides a timely and unique opportunity to present breaking cancer research to one of the largest and most diverse audiences in global oncology.
  • Your live presentation will be accessible to virtual attendees and available on-demand on the ASCO Meeting Experience.
  • Your abstract will be published on ASCO.org and in a supplement to the Journal of Clinical Oncology.
  • Abstracts selected for the Plenary Series will be placed in a high-profile session for oral presentation at the ASCO Annual Meeting.

Visit ASCO's submission guidelines and policies for more information as you prepare for your submission.

Headshot of Dr. George Sledge“The ASCO Plenary Series allows us, as the world’s premier venue for clinical cancer research, to keep up with the explosive pace of important and clinically relevant new developments. Bringing the best research to our patients in a timely fashion will save lives, an exciting prospect for our members.”

—George W. Sledge, Jr., MD, FASCO, Chair, Plenary Series Scientific Review Committee

Program

The inaugural ASCO Plenary Series session will take place on November 16, 2021. This will include the presentation and discussion of up to two high-impact clinically relevant abstracts. ASCO Annual Meeting registrants will have access to all Plenary series content, including the live presentation as well as on-demand slides and videos following the presentation. Stay tuned for more program details including the release of abstract titles and authors.

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15